These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33970224)

  • 1. CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors.
    Manfra O; Calamera G; Froese A; Arunthavarajah D; Surdo NC; Meier S; Melleby AO; Aasrum M; Aronsen JM; Nikolaev VO; Zaccolo M; Moltzau LR; Levy FO; Andressen KW
    Cardiovasc Res; 2022 May; 118(6):1506-1519. PubMed ID: 33970224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
    Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
    Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
    Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
    Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
    Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.
    Moltzau LR; Aronsen JM; Meier S; Nguyen CH; Hougen K; Ørstavik Ø; Sjaastad I; Christensen G; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Br J Pharmacol; 2013 Sep; 170(2):366-79. PubMed ID: 23808942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
    Crook RB; Chang AT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
    Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
    Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.
    Afzal F; Qvigstad E; Aronsen JM; Moltzau LR; Sjaastad I; Skomedal T; Osnes JB; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):543-53. PubMed ID: 21901315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct submembrane localisation compartmentalises cardiac NPR1 and NPR2 signalling to cGMP.
    Subramanian H; Froese A; Jönsson P; Schmidt H; Gorelik J; Nikolaev VO
    Nat Commun; 2018 Jun; 9(1):2446. PubMed ID: 29934640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
    Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased effects of C-type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP-dependent protein kinase I.
    Wollert KC; Yurukova S; Kilic A; Begrow F; Fiedler B; Gambaryan S; Walter U; Lohmann SM; Kuhn M
    Br J Pharmacol; 2003 Dec; 140(7):1227-36. PubMed ID: 14609817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of C-type natriuretic peptide on rat astrocytes: regional differences and characterization of receptors.
    Deschepper CF; Picard S
    J Neurochem; 1994 May; 62(5):1974-82. PubMed ID: 7908948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
    Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
    J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of C-type natriuretic peptide on rat cardiac contractility.
    Brusq JM; Mayoux E; Guigui L; Kirilovsky J
    Br J Pharmacol; 1999 Sep; 128(1):206-12. PubMed ID: 10498853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
    Kaneki H; Kurokawa M; Ide H
    J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
    Herring N; Zaman JA; Paterson DJ
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2318-27. PubMed ID: 11709398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling.
    Lee SJ; Kim SZ; Cui X; Kim SH; Lee KS; Chung YJ; Cho KW
    Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H208-21. PubMed ID: 10644601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
    Sellitti DF; Puggina E; Lagranha C; Doi SQ
    J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.